Page last updated: 2024-09-03

6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and Antibody Deficiency Syndrome

6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine has been researched along with Antibody Deficiency Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ammann, S; Brandau, H; Bredius, R; Burns, SO; Dückers, G; Edgar, JD; Ehl, S; Elling, R; Gyrd-Hansen, M; Hasselblatt, P; Schwarz, K; Speckmann, C; Warnatz, K; Worth, A; Zur Stadt, U1

Other Studies

1 other study(ies) available for 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and Antibody Deficiency Syndrome

ArticleYear
A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency.
    Clinical and experimental immunology, 2014, Volume: 176, Issue:3

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Case-Control Studies; Child; Child, Preschool; Female; Flow Cytometry; Humans; Immunologic Deficiency Syndromes; Immunophenotyping; Infant; Leukocytes, Mononuclear; Male; Middle Aged; Mutation; Nod2 Signaling Adaptor Protein; Phenotype; T-Lymphocytes; Tumor Necrosis Factors; X-Linked Inhibitor of Apoptosis Protein; Young Adult

2014